Physician

William W. Robison, M.D.

According to 2025 Medicare claims, William Robison, M.D. (NPI: 1467457325) practices internal medicine in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is CLINICS OF NORTH TEXAS LLP (NPI: 1720067358; TIN: 75-0867304) and primary practice location at 76302-2302. Robison is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Robison's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 521 traditional Medicare patients, billed 9,603 HCPCS/CPT codes, and received $279,506 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,883 prescription claims across 598 beneficiaries totaling $1,248,525 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 684 claims. Open Payments data shows 142 records totaling $2,615. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $882,204 to $1,248,525. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $24,276 to $53,516.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	780	19,745	$335,757
2016	739	19,055	$326,036
2017	742	16,640	$329,253
2018	710	15,218	$322,037
2019	676	14,811	$333,514
2020	652	15,557	$293,099
2021	714	16,431	$279,550
2022	581	11,842	$249,518
2023	550	9,153	$263,893
2024	521	9,603	$279,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	628	11,251	$882,204
2016	651	11,729	$880,660
2017	662	11,668	$835,991
2018	667	11,458	$816,517
2019	694	11,461	$965,860
2020	698	11,824	$1,116,574
2021	662	11,269	$1,148,992
2022	644	11,001	$1,179,819
2023	645	10,929	$1,399,852
2024	598	10,883	$1,248,525

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	84	388	$11,839
2016	228	649	$22,692
2017	296	778	$20,311
2018	309	926	$28,807
2019	257	794	$28,592
2020	390	1,096	$51,830
2021	329	958	$44,762
2022	320	854	$46,852
2023	298	887	$50,404
2024	270	684	$48,964

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	371	371	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	427	1,055	$80
80053	Blood test, comprehensive group of blood chemicals	304	344	$10
36415	Insertion of needle into vein for collection of blood sample	415	916	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	339	501	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	189	5,730	$197,798
Ozempic	Semaglutide	149	5,836	$179,778
Eliquis	Apixaban	139	7,265	$136,394
Jardiance	Empagliflozin	69	3,750	$65,459
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	2,070	$43,250

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	12	56	$24,752
A7032	Cushion for use on nasal mask interface, replacement only, each	N	16	43	$4,487
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	28	73	$4,030
A7031	Face mask interface, replacement for full face mask, each	N	14	41	$3,619
A7030	Full face mask used with positive airway pressure device, each	N	15	40	$3,272

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$2,615	Corcept Therapeutics
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William W. Robison, M.D.?

Tedicare shows public-source Medicare data for William W. Robison, M.D. (NPI 1467457325), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William W. Robison, M.D. have ACO affiliation data?

William W. Robison, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to William W. Robison, M.D.?

William W. Robison, M.D. is linked to CLINICS OF NORTH TEXAS LLP (billing NPI 1720067358) in the available physician profile data.

Does William W. Robison, M.D. have Open Payments data?

William W. Robison, M.D. has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.